BackChina Pharma Holdings Overview

China Pharma Holdings Property, Plant & Equipment

Latest property, plant & equipment for CPHI: $4.4T.

Get informed when a big investor buys or sells

+ Follow
PPE
$4365.94B
↑ 103154203.43% YoYΔ $4365.94B vs prior year quarter

Peer trimmed avg / median

Loading

China Pharma Holdings PPE History

Loading

China Pharma Holdings vs. peers: PPE Comparison

Loading

China Pharma Holdings PPE Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China Pharma Holdings (CPHI) FAQ

As of the most recent data (June 2026), CPHI shows a PP&E of $4.4T. That compares with $4.2M in the prior-year period — up 103154203.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CPHI's PP&E is now $4.4T (was $4.2M) — a 103154203.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether China Pharma Holdings is outperforming or lagging.

Tracking CPHI's property, plant & equipment over time shows whether China Pharma Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $4.4T That compares with $4.2M in the prior-year period — up 103154203.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this property, plant & equipment page, Stockcircle has China Pharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PP&E (currently $4.4T) with ownership activity and broader fundamentals.

China Pharma Holdings's PP&E is $4.4T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.